secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001628280-24-022216
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cibus Q1 net loss $27.0M; cash runway into Q3 2024; EU regulatory progress and wheat platform breakthrough
--------------------------------------------------------------------------------

- Net loss $27.0M ($1.12 per share) vs $5.4M in prior period; year-over-year not comparable due to business combination.
- Cash and equivalents $24.5M; existing funds expected to cover operations only into Q3 2024 without new financing.
- R&D expense $12.0M (up $9.8M) and SG&A $7.0M (up $4.7M), driven by headcount, stock comp, and facility costs.
- EU Parliament voted to support NGT regulation similar to conventional breeding; wheat single-cell regeneration completed.
- Signed three rice trait agreements (Loveland Products, Interoc); soybean platform expected operational in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000162828024022216/0001628280-24-022216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000162828024022216/cbus-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-022216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer